Joseph Eid

CIK: 0001780247

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GERN

GERON CORP

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

GERN
GERON CORP
Feb 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
2.2M shares-
GERN
GERON CORP
Nov 11, 2024
Award(A)
Stock Option (right to buy)
Direct
2.5M shares-

		Type	Shares	Price		Ownership
Feb 17, 2026	GERN GERON CORP	Award(A) Stock Option (Right to Buy)	2,220,000	-	-	Direct
Nov 11, 2024	GERN GERON CORP	Award(A) Stock Option (right to buy)	2,500,000	-	-	Direct

1-2 of 2 transactions

About Eid Joseph

Eid Joseph (SEC CIK 0001780247) files insider reports with the SEC as EVP, R&D; Chief Medical Office of GERON CORP (GERN).

Signal8 holds 3 ownership filings by Eid Joseph (1 Form 3, 2 Form 4), filed between Nov 12, 2024 and Feb 19, 2026. Those filings report 2 transactions, from Nov 11, 2024 to Feb 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Eid Joseph's filings is in FOSTER CITY, CA.

Recent filings by Eid Joseph

Feb 17, 2026: Grant or award of GERN derivative securities (Form 4, code A).
Nov 11, 2024: Grant or award of GERN derivative securities (Form 4, code A).

Other insiders filing for GERON CORP (GERN)

Spiegel Robert J., Director
O'Farrell Elizabeth G., Director
Molineaux Susan, Director
McDonald John F, Director
Bir Dawn Carter, Director
Williams Timothy, EVP and Chief Legal Officer

How to read Form 4 transaction codes